{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:31:47Z","timestamp":1777555907926,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01-HL98416"],"award-info":[{"award-number":["R01-HL98416"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R37-HD28607"],"award-info":[{"award-number":["R37-HD28607"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ymthe.2017.05.014","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T16:01:13Z","timestamp":1497110473000},"page":"1686-1696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Enhanced Delivery and Effects of Acid Sphingomyelinase by ICAM-1-Targeted Nanocarriers in Type B Niemann-Pick Disease Mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Carmen","family":"Garnacho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajwinder","family":"Dhami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melani","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward H.","family":"Schuchman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Muro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2017.05.014_bib1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s10545-007-0632-9","article-title":"The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease","volume":"30","author":"Schuchman","year":"2007","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2017.05.014_bib2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00408-016-9893-0","article-title":"Pulmonary involvement in Niemann-Pick disease: a state-of-the-art review","volume":"194","author":"von Ranke","year":"2016","journal-title":"Lung"},{"key":"10.1016\/j.ymthe.2017.05.014_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.beem.2014.10.002","article-title":"Types A and B Niemann-Pick disease","volume":"29","author":"Schuchman","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2017.05.014_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.embor.7400208","article-title":"The complex life of simple sphingolipids","volume":"5","author":"Futerman","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ymthe.2017.05.014_bib5","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/PAS.0b013e31825793ff","article-title":"Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B)","volume":"36","author":"Thurberg","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ymthe.2017.05.014_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ymgme.2016.05.001","article-title":"Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): literature review and report of new cases","volume":"118","author":"Cassiman","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.05.014_bib7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gim.2013.4","article-title":"Morbidity and mortality in type B Niemann-Pick disease","volume":"15","author":"McGovern","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2017.05.014_bib8","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1096\/fj.00-0014com","article-title":"Infusion of recombinant human acid sphingomyelinase into Niemann-Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology","volume":"14","author":"Miranda","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2017.05.014_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymgme.2009.01.008","article-title":"Pulmonary delivery of recombinant acid sphingomyelinase improves clearance of lysosomal sphingomyelin from the lungs of a murine model of Niemann-Pick disease","volume":"97","author":"Ziegler","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.05.014_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/gim.2015.24","article-title":"Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency)","volume":"18","author":"McGovern","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2017.05.014_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/wnan.73","article-title":"New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders","volume":"2","author":"Muro","year":"2010","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ymthe.2017.05.014_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ymgme.2014.07.005","article-title":"Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency: the utility of animal models of disease in the toxicological evaluation of potential therapeutics","volume":"114","author":"Murray","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.05.014_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgme.2015.05.013","article-title":"Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency","volume":"116","author":"Wasserstein","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.05.014_bib14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/jpet.107.133298","article-title":"Delivery of acid sphingomyelinase in normal and Niemann-Pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers","volume":"325","author":"Garnacho","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymthe.2017.05.014_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10545-012-9534-6","article-title":"Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor","volume":"36","author":"Papademetriou","year":"2013","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2017.05.014_bib16","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.biomaterials.2013.01.069","article-title":"In\u00a0vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors","volume":"34","author":"Papademetriou","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2017.05.014_bib17","series-title":"Endothelial Biomedicine","first-page":"1058","article-title":"VCAM-1 and ICAM-1","author":"Muro","year":"2007"},{"key":"10.1016\/j.ymthe.2017.05.014_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ymthe.2005.07.687","article-title":"Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis","volume":"13","author":"Muro","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.05.014_bib19","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/mt.2008.127","article-title":"Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers","volume":"16","author":"Muro","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.05.014_bib20","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/mp500241y","article-title":"Clathrin-mediated endocytosis is impaired in type A-B Niemann-Pick disease model cells and can be restored by ICAM-1-mediated enzyme replacement","volume":"11","author":"Rappaport","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2017.05.014_bib21","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/mp5005959","article-title":"Altered clathrin-independent endocytosis in type A Niemann-Pick disease cells and rescue by ICAM-1-targeted enzyme delivery","volume":"12.5","author":"Rappaport","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2017.05.014_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/acs.molpharmaceut.5b00542","article-title":"A comparative study on the alterations of endocytic pathways in multiple lysosomal storage disorders","volume":"13","author":"Rappaport","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2017.05.014_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jconrel.2010.10.031","article-title":"Enhanced endothelial delivery and biochemical effects of \u03b1-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease","volume":"149","author":"Hsu","year":"2011","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2017.05.014_bib24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.nano.2011.08.014","article-title":"Enhanced delivery of \u03b1-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders","volume":"8","author":"Hsu","year":"2012","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.ymthe.2017.05.014_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1166\/jbn.2014.1718","article-title":"Enhancing biodistribution of therapeutic enzymes in\u00a0vivo by modulating surface coating and concentration of ICAM-1-targeted nanocarriers","volume":"10","author":"Hsu","year":"2014","journal-title":"J.\u00a0Biomed. Nanotechnol."},{"key":"10.1016\/j.ymthe.2017.05.014_bib26","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1124\/jpet.105.098970","article-title":"Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1","volume":"317","author":"Muro","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymthe.2017.05.014_bib27","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2004-05-1714","article-title":"ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs","volume":"105","author":"Muro","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2017.05.014_bib28","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1242\/jcs.00367","article-title":"A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1","volume":"116","author":"Muro","year":"2003","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ymthe.2017.05.014_bib29","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1161\/ATVBAHA.111.244186","article-title":"Intercellular adhesion molecule 1 engagement modulates sphingomyelinase and ceramide, supporting uptake of drug carriers by the vascular endothelium","volume":"32","author":"Serrano","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymthe.2017.05.014_bib30","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s11095-013-1289-8","article-title":"Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood-brain barrier","volume":"31","author":"Hsu","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ymthe.2017.05.014_bib31","doi-asserted-by":"crossref","first-page":"L518","DOI":"10.1152\/ajplung.00258.2002","article-title":"Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease","volume":"284","author":"Ikegami","year":"2003","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ymthe.2017.05.014_bib32","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ng0795-288","article-title":"Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease","volume":"10","author":"Horinouchi","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.05.014_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2010.10.025","article-title":"Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers","volume":"150","author":"Calderon","year":"2011","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2017.05.014_bib34","doi-asserted-by":"crossref","first-page":"10597","DOI":"10.1021\/nn404719c","article-title":"Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting","volume":"7","author":"Ansar","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2017.05.014_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0167-4838(99)00069-2","article-title":"Characterization of human acid sphingomyelinase purified from the media of overexpressing Chinese hamster ovary cells","volume":"1432","author":"He","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2017.05.014_bib36","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1021\/acs.biomac.6b00493","article-title":"How carrier size and valency modulate receptor-mediated signaling: understanding the link between binding and endocytosis of ICAM-1-targeted carriers","volume":"17","author":"Serrano","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ymthe.2017.05.014_bib37","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1182\/blood-2007-06-098657","article-title":"RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1","volume":"111","author":"Garnacho","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2017.05.014_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/abio.2002.5686","article-title":"A fluorescence-based, high-throughput sphingomyelin assay for the analysis of Niemann-Pick disease and other disorders of sphingomyelin metabolism","volume":"306","author":"He","year":"2002","journal-title":"Anal. Biochem."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617302320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617302320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:52:38Z","timestamp":1535763158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617302320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1525001617302320"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.05.014","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced Delivery and Effects of Acid Sphingomyelinase by ICAM-1-Targeted Nanocarriers in Type B Niemann-Pick Disease Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}